Skip to main content
Clinical Trials/NCT06197685
NCT06197685
Recruiting
N/A

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

Kessler Foundation1 site in 1 country78 target enrollmentFebruary 12, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Kessler Foundation
Enrollment
78
Locations
1
Primary Endpoint
Change in objective new learning and memory (NLM).
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

The goal of this novel study is to compare the effect of a combined cognitive rehabilitation and exercise approach on new learning and memory (NLM) in persons with multiple sclerosis (pwMS) and mobility disability.

Detailed Description

The proposed research study will be the first to apply the Kessler Foundation modified Story Memory Technique (KF-mSMT®), the practice standard for cognitive rehabilitation, with one of two exercise programs. Alone, KF-mSMT® has been beneficial to NLM impairment, however, its effects are highly selective to list learning and as such, will not maximally restore NLM function. The combination of KF-mSMT® and exercise provides a robust approach towards maximal functional recovery.

Registry
clinicaltrials.gov
Start Date
February 12, 2024
End Date
June 30, 2026
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kessler Foundation
Responsible Party
Principal Investigator
Principal Investigator

Carly Wender

Research Scientist

Kessler Foundation

Eligibility Criteria

Inclusion Criteria

  • Be within the ages of 18 and 70 years of age
  • Speak English as their primary language
  • Confirmed MS diagnosis by a neurologist
  • Be relapse and steroid-free for at least 30 days
  • Mild-to-moderate self-reported mobility disability, based on the Patient Determined Disease Steps scale (PDDS)
  • Currently physically inactive, based on the Godin Leisure Time Exercise Questionnaire (GLTEQ)
  • Right handedness

Exclusion Criteria

  • History of neurological disorders besides MS or history of uncontrolled psychiatric disorders (ex: major depression)
  • Have contraindications to exercise, based on the Physical Activity Readiness Questionnaire (PAR-Q)
  • Currently use medications that may impact cognition (ex: steroids, benzodiazepines)
  • Currently pregnant
  • Contraindication for MRI (metal or electronic devices in the body that are not considered MRI safe)
  • Severe cognitive impairment as measured by the Modified Telephone Interview of Cognitive Status (TICS-M)

Outcomes

Primary Outcomes

Change in objective new learning and memory (NLM).

Time Frame: Weeks 1 and 2 (pre-intervention) and Weeks 15 and 16 (post-intervention)

The California Verbal Learning Test-Second Edition (CVLT-II) measures verbal learning and memory by having participants recall a list of words from 4 semantic categories. The word list is presented over 5 trials with a 20 minute delayed recall and recognition trial. Standardized T-scores range from 0-100, where higher scores indicated better performance.

Change in everyday memory

Time Frame: Weeks 1 and 2 (pre-intervention) and Weeks 15 and 16 (post-intervention)

The Ecological Memory Simulations (EMS) is a multi-component test that measures memory as it relates to everyday life. Scores range from 0-205, where higher scores indicated better performance.

Secondary Outcomes

  • Change in hippocampal volume(Weeks 1 and 2 (pre-intervention) and Weeks 15 and 16 (post-intervention))
  • Change in hippocampal function(Weeks 1 and 2 (pre-intervention) and Weeks 15 and 16 (post-intervention))

Study Sites (1)

Loading locations...

Similar Trials